Novel tool helps identify key targets to strengthen CAR NK cell therapies
Researchers developed the first genome-wide CRISPR screening tool for primary human natural killer (NK) cells
Study revealed critical regulators of NK cell activity that can be targeted to improve chimeric antigen receptor (CAR) NK cell therapies
Findings open new avenues for developing more effective CAR NK cell therapies for many cancers
HOUSTON, AUGUST 21, 2025 ― Natural killer (NK) cells became markedly better at killing cancer...
Cancer-associated nerve injury leads to chronic inflammation and immunotherapy resistance
Study finds cancer cells break down protective nerve coverings, leading to nerve injury and chronic inflammation
These nerve injuries drive...
MD Anderson awards top honors to exceptional faculty
HOUSTON ― The University of Texas MD Anderson Cancer Center honored more than 100 faculty members Thursday night during its annual Celebration...